These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15383460)

  • 21. Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression.
    Schowalter DB; Meuse L; Wilson CB; Linsley PS; Kay MA
    Gene Ther; 1997 Aug; 4(8):853-60. PubMed ID: 9338015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic control of the immune response to ferredoxin: linkage and mapping of T cell proliferation and antibody production genes to the MHC of mice.
    Sikora LK; Levy JG
    J Immunol; 1980 Jun; 124(6):2615-9. PubMed ID: 6768798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of MHC background on the antibody response to detergent enzymes in the mouse intranasal test.
    Sarlo K; Parris JS; Clark ED; Horn PA; Robinson MK; McCay JA; Peachee VL; Veloso YL; White KL
    Toxicol Sci; 2000 Dec; 58(2):299-305. PubMed ID: 11099642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful expression of human factor IX following repeat administration of adenoviral vector in mice.
    Walter J; You Q; Hagstrom JN; Sands M; High KA
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3056-61. PubMed ID: 8610167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired antibody responses in H-2Ab mice.
    Gustavsson S; Hjulström-Chomez S; Lidström BM; Ahlborg N; Andersson R; Heyman B
    J Immunol; 1998 Aug; 161(4):1765-71. PubMed ID: 9712042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Susceptibility to a mouse acquired immunodeficiency syndrome is influenced by the H-2.
    Hamelin-Bourassa D; Skamene E; Gervais F
    Immunogenetics; 1989; 30(4):266-72. PubMed ID: 2551819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of specific CD4 and CD8 T cell epitopes after AAV2- and AAV8-hF.IX gene therapy.
    Chen J; Wu Q; Yang P; Hsu HC; Mountz JD
    Mol Ther; 2006 Feb; 13(2):260-9. PubMed ID: 16324888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs.
    Kay MA; Landen CN; Rothenberg SR; Taylor LA; Leland F; Wiehle S; Fang B; Bellinger D; Finegold M; Thompson AR
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2353-7. PubMed ID: 8134398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenovirus-mediated transfer of human factor IX gene in immunodeficient and normal mice: evidence for prolonged stability and activity of the transgene in liver.
    Yao SN; Farjo A; Roessler BJ; Davidson BL; Kurachi K
    Viral Immunol; 1996; 9(3):141-53. PubMed ID: 8890472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel hemophilia B mouse models exhibiting a range of mutations in the Factor IX gene.
    Sabatino DE; Armstrong E; Edmonson S; Liu YL; Pleimes M; Schuettrumpf J; Fitzgerald J; Herzog RW; Arruda VR; High KA
    Blood; 2004 Nov; 104(9):2767-74. PubMed ID: 15217833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice.
    Smith TA; Mehaffey MG; Kayda DB; Saunders JM; Yei S; Trapnell BC; McClelland A; Kaleko M
    Nat Genet; 1993 Dec; 5(4):397-402. PubMed ID: 8298650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibody characterization of a unique immune response control locus between H-2S and D.
    Shapiro LH; Dugan ES; Neiderhuber JE
    J Exp Med; 1985 Nov; 162(5):1477-93. PubMed ID: 3932577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. H-2-linked genetic control of the in vivo response to a spontaneous mutant minor histocompatibility antigen in the mouse.
    Melvold RW; Beck-Maier BH
    J Immunol; 1981 Aug; 127(2):813-5. PubMed ID: 6788850
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic control of the immune response to staphylococcal nuclease. I. Ir-Nase: control of the antibody response to nuclease by the Ir region of the mouse H-2 complex.
    Lozner EC; Sachs DH; Shearer GM
    J Exp Med; 1974 May; 139(5):1204-14. PubMed ID: 4825243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technology evaluation: AAV factor IX gene therapy, Avigen Inc.
    Fabb SA; Dickson JG
    Curr Opin Mol Ther; 2000 Oct; 2(5):601-6. PubMed ID: 11249763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Responses against antigens encoded by the H-3 histocompatibility locus: antigens stimulating class I MHC- and class II MHC-restricted T cells are encoded by separate genes.
    Roopenian DC; Davis AP
    Immunogenetics; 1989; 30(5):335-43. PubMed ID: 2530167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia.
    Monahan PE; Samulski RJ; Tazelaar J; Xiao X; Nichols TC; Bellinger DA; Read MS; Walsh CE
    Gene Ther; 1998 Jan; 5(1):40-9. PubMed ID: 9536263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of hemophilia B in mice with nonautologous somatic gene therapeutics.
    Van Raamsdonk JM; Ross CJ; Potter MA; Kurachi S; Kurachi K; Stafford DW; Chang PL
    J Lab Clin Med; 2002 Jan; 139(1):35-42. PubMed ID: 11873243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic and nongenetic control of the immune response of mice to a synthetic glycolipid, stearylisomaltotetraose.
    Lai E; Kabat EA; Mobraaten L
    Cell Immunol; 1985 Apr; 92(1):172-83. PubMed ID: 3935333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenovirus-mediated expression of human coagulation factor IX in the rhesus macaque is associated with dose-limiting toxicity.
    Lozier JN; Metzger ME; Donahue RE; Morgan RA
    Blood; 1999 Dec; 94(12):3968-75. PubMed ID: 10590040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.